|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,875.00 JPY | +1.25% |
|
-1.32% | -27.35% |
| 01-29 | Eslead Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025 | CI |
| 12-24 | Eslead Corporation Enters into a Syndicated Loan Agreement with Financial Covenants | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 69B | 74.6B | 79.91B | 80.29B | 94.76B | |||||
Total Revenues | 69B | 74.6B | 79.91B | 80.29B | 94.76B | |||||
Cost of Goods Sold, Total | 54.42B | 57.55B | 61.78B | 59.93B | 70.96B | |||||
Gross Profit | 14.58B | 17.05B | 18.13B | 20.35B | 23.81B | |||||
Selling General & Admin Expenses, Total | 6.47B | 7.36B | 7.24B | 7B | 6.9B | |||||
Depreciation & Amortization - (IS) | 77M | 105M | 123M | 127M | 124M | |||||
Other Operating Expenses | 1.01B | 923M | 1.29B | 1.6B | 2.23B | |||||
Other Operating Expenses, Total | 7.56B | 8.39B | 8.65B | 8.72B | 9.26B | |||||
Operating Income | 7.02B | 8.66B | 9.48B | 11.63B | 14.55B | |||||
Interest Expense, Total | -200M | -287M | -374M | -518M | -996M | |||||
Interest And Investment Income | - | - | 12M | 32M | 28M | |||||
Net Interest Expenses | -200M | -287M | -362M | -486M | -968M | |||||
Other Non Operating Income (Expenses) | 182M | 201M | 249M | 200M | 167M | |||||
EBT, Excl. Unusual Items | 7B | 8.57B | 9.37B | 11.34B | 13.75B | |||||
Asset Writedown | - | - | -35M | -3M | - | |||||
Other Unusual Items | - | - | 35M | - | - | |||||
EBT, Incl. Unusual Items | 7B | 8.57B | 9.37B | 11.34B | 13.75B | |||||
Income Tax Expense | 2.5B | 3.15B | 3.22B | 3.82B | 4.42B | |||||
Earnings From Continuing Operations | 4.51B | 5.43B | 6.15B | 7.52B | 9.33B | |||||
Net Income to Company | 4.51B | 5.43B | 6.15B | 7.52B | 9.33B | |||||
Net Income - (IS) | 4.51B | 5.43B | 6.15B | 7.52B | 9.33B | |||||
Net Income to Common Incl Extra Items | 4.51B | 5.43B | 6.15B | 7.52B | 9.33B | |||||
Net Income to Common Excl. Extra Items | 4.51B | 5.43B | 6.15B | 7.52B | 9.33B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 292.03 | 351.81 | 398.41 | 487.26 | 604.71 | |||||
Basic EPS - Continuing Operations | 292.03 | 351.81 | 398.41 | 487.26 | 604.71 | |||||
Basic Weighted Average Shares Outstanding | 15.43M | 15.43M | 15.43M | 15.43M | 15.43M | |||||
Net EPS - Diluted | 292.03 | 351.81 | 398.41 | 487.26 | 604.71 | |||||
Diluted EPS - Continuing Operations | 292.03 | 351.81 | 398.41 | 487.26 | 604.71 | |||||
Diluted Weighted Average Shares Outstanding | 15.43M | 15.43M | 15.43M | 15.43M | 15.43M | |||||
Normalized Basic EPS | 283.58 | 347.32 | 379.48 | 459.56 | 556.87 | |||||
Normalized Diluted EPS | 283.58 | 347.32 | 379.48 | 459.56 | 556.87 | |||||
Dividend Per Share | 40 | 40 | 90 | 150 | 185 | |||||
Payout Ratio | 13.67 | 11.35 | 15.05 | 22.56 | 28.93 | |||||
Supplemental Items | ||||||||||
EBITDA | 7.28B | 9B | 9.9B | 12.18B | 15.1B | |||||
EBITA | 7.02B | 8.68B | 9.52B | 11.67B | 14.58B | |||||
EBIT | 7.02B | 8.66B | 9.48B | 11.63B | 14.55B | |||||
Effective Tax Rate - (Ratio) | 35.64 | 36.69 | 34.38 | 33.72 | 32.13 | |||||
Normalized Net Income | 4.38B | 5.36B | 5.86B | 7.09B | 8.59B | |||||
Non-Cash Pension Expense | 30.91M | 28.82M | 35.2M | 35.39M | 61.82M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 540M | 690M | 807M | 662M | 504M | |||||
Selling and Marketing Expenses | 540M | 690M | 807M | 662M | 504M |
- Stock Market
- Stocks
- 8877 Stock
- Financials Eslead Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















